The bone graft uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine. The implantation occurred in Europe and opened the doors for global distribution.
More Articles on Spine Devices:
AxioMed Spine Receives CE Mark for cervical Disc
TransCorp Spine Names Christopher Welch President & CEO
6 New Spine Device Company Financial Reports
a
Pioneer Surgical Technology's nanOss Bioactive Bone Graft Implanted in Posterolateral Spine
Written by Laura Miller | May 30, 2012
Pioneer Surgical Technology announced its nanOss Bioactive bone graft has been successfully implanted into a human.
Tagged under
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.